5-Amino-1MQ
A small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), studied for its influence on cellular NAD+ availability and adipose tissue metabolism. One of the most closely watched compounds in metabolic and longevity research.
One enzyme, precisely targeted.
5-Amino-1MQ is not a peptide. It is a small quinolinium molecule that blocks a single enzyme, nicotinamide N-methyltransferase, and that narrow mechanism is exactly what makes it interesting. NNMT sits at a metabolic crossroads, consuming both nicotinamide (a direct NAD+ precursor) and S-adenosylmethionine, the primary methyl donor a cell has to work with.
NMT is expressed at unusually high levels in white adipose tissue, and that expression climbs in models of obesity and metabolic dysfunction. When researchers reduced NNMT activity in diet-induced obese mice, published studies reported decreases in fat mass and adipocyte size with no change in food intake, a result that pointed toward energy metabolism rather than appetite.
Later work moved into muscle and aging biology, where NNMT inhibition has been examined for its effects on aged muscle stem cell function and regenerative capacity. For research focused on women, the intersection of adipose distribution, declining NAD+, and the metabolic shifts of midlife makes NNMT one of the more relevant enzymes in the field.